Certolizumab pegol Terminated Phase 4 Trials for Crohn's Disease (CD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01696942Cimzia Versus Mesalamine for Crohn's Recurrence